Home › NDC Lookup › RxCUI directory › RxCUI 577961

Amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG... — RxCUI 577961

RxNorm drug concept · Semantic clinical drug
RxCUI 577961 Semantic clinical drug · SCD ● Current RxNorm concept 120 FDA products 179 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI577961
Official nameAmphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmixed amphetamine salts 20 MG Oral Tablet
FDA products mapped120
Package NDCs mapped179
Reported Medicaid activity (SDUD)4,458,714 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextroamphetamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It sounds counterintuitive, but stimulants actually calm things down for many people with ADHD. Dextroamphetamine boosts dopamine and norepinephrine — two brain chemicals involved...
  • What exactly does dextroamphetamine do, and why does a stimulant help with ADHD?
  • The most common ones are decreased appetite, trouble sleeping, and headache — and decreased appetite is very common, especially early on. Taking doses too late in the day tends to...
  • What are the most common side effects I should expect?
📖 Read our full Dextroamphetamine guide →

🕸️ Concept Web — How Amphetamine aspartate 5 MG / amphetamine sulfate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet RxCUI 577961

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 7

    The active substance itself — no strength, form, or brand attached yet.

    • Amphetamine 725
    • Dextroamphetamine 3288
    • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate 822929
    • Amphetamine aspartate 221057
    • Amphetamine sulfate 81952
    • Dextroamphetamine saccharate 221088
    • Dextroamphetamine sulfate 3287
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Adderall 84815
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amphetamine / dextroamphetamine Oral Tablet 376410
    • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Oral Tablet 2649211
    • Amphetamine / dextroamphetamine Oral Product 1152902
    • Amphetamine / dextroamphetamine Pill 1152903
    • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Oral Product 2663336
    • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Pill 2661494
    • Amphetamine / dextroamphetamine Oral Tablet [Adderall] 577959
    • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Oral Tablet [Adderall] 2656747
    • +5 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 22 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amphetamine aspartate 5 MG SCDC · 541770
  • Amphetamine sulfate 5 MG SCDC · 484707
  • Dextroamphetamine saccharate 5 MG SCDC · 484709
  • Dextroamphetamine sulfate 5 MG SCDC · 578398
  • Amphetamine / dextroamphetamine Oral Tablet SCDF · 376410
  • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Oral Tablet SCDFP · 2649211
  • Amphetamine / dextroamphetamine Oral Product SCDG · 1152902
  • Amphetamine / dextroamphetamine Pill SCDG · 1152903
  • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Oral Product SCDGP · 2663336
  • Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate Pill SCDGP · 2661494

Brand-Name Concepts

📦 FDA Products & Package NDCs

120 products · 179 package NDCs
179 package NDCs map to RxCUI 577961 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68462-0649-01 100 TABLET in 1 BOTTLE (68462-649-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate GLENMARK PHARMACEUTICALS INC., USA 2025-05-12
68462-0651-01 100 TABLET in 1 BOTTLE (68462-651-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate GLENMARK PHARMACEUTICALS INC., USA 2025-05-12
68462-0652-01 100 TABLET in 1 BOTTLE (68462-652-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate GLENMARK PHARMACEUTICALS INC., USA 2025-05-12
68462-0653-01 100 TABLET in 1 BOTTLE (68462-653-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate GLENMARK PHARMACEUTICALS INC., USA 2025-05-12
70010-0111-01 100 TABLET in 1 BOTTLE (70010-111-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0111-03 30 TABLET in 1 BOTTLE (70010-111-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
70010-0112-01 100 TABLET in 1 BOTTLE (70010-112-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0112-03 30 TABLET in 1 BOTTLE (70010-112-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
70010-0113-01 100 TABLET in 1 BOTTLE (70010-113-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0113-03 30 TABLET in 1 BOTTLE (70010-113-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0114-01 100 TABLET in 1 BOTTLE (70010-114-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0114-03 30 TABLET in 1 BOTTLE (70010-114-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
70010-0115-01 100 TABLET in 1 BOTTLE (70010-115-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0115-03 30 TABLET in 1 BOTTLE (70010-115-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
70010-0116-01 100 TABLET in 1 BOTTLE (70010-116-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0116-03 30 TABLET in 1 BOTTLE (70010-116-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
70010-0117-01 100 TABLET in 1 BOTTLE (70010-117-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2023-03-28
70010-0117-03 30 TABLET in 1 BOTTLE (70010-117-03) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Granules Pharmaceuticals Inc. 2024-04-30
72162-2053-01 100 TABLET in 1 BOTTLE (72162-2053-1) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Bryant Ranch Prepack 2023-06-14
72162-2053-03 30 TABLET in 1 BOTTLE (72162-2053-3) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Bryant Ranch Prepack 2023-06-14
72162-2053-06 60 TABLET in 1 BOTTLE (72162-2053-6) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Bryant Ranch Prepack 2023-06-14
72162-2053-09 90 TABLET in 1 BOTTLE (72162-2053-9) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Bryant Ranch Prepack 2023-06-14
72162-2251-01 100 TABLET in 1 BOTTLE (72162-2251-1) DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Bryant Ranch Prepack 2024-02-08
72516-0011-01 100 TABLET in 1 BOTTLE (72516-011-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
72516-0012-01 100 TABLET in 1 BOTTLE (72516-012-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
72516-0013-01 100 TABLET in 1 BOTTLE (72516-013-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
72516-0014-01 100 TABLET in 1 BOTTLE (72516-014-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
72516-0015-01 100 TABLET in 1 BOTTLE (72516-015-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
72516-0016-01 100 TABLET in 1 BOTTLE (72516-016-01) Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc. 2020-10-19
Observed labelers: Aurolife Pharma, LLC (35) · Elite Laboratories, Inc. (21) · Granules Pharmaceuticals Inc. (14) · SUNRISE PHARMACEUTICAL, INC. (14) · Teva Pharmaceuticals USA, Inc. (14) · Camber Pharmaceuticals, Inc. (7) · +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.